Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for Gastric Visualization in UGIB
NCT06167837Phase 4Recruiting
- Start
- Oct 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in upper gastrointestinal bleeding (UGIB) comparing Metoclopramide group with Placebo group (2 arms). Primary endpoint: Percentage of patients with adequate visualization. Started Oct 2023; status: recruiting.
02
Drugs
metoclopramide
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT06167837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06167837.